Genomics and cardiovascular disease

Journal of Nursing Scholarship

Volumn 37, Issue 4, 2005, Pages 315-321

  Frazier, Lorraine ^a,d   Johnson, Rolanda L ^b   Sparks, Elizabeth ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Cardiomyopathy; Cardiovascular disease; Genomics

Indexed keywords

ADULT; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE THERAPY; GENETIC COUNSELING; GENETICS; HUMAN; MALE; PATHOPHYSIOLOGY; REVIEW;

ADULT; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; GENE THERAPY; GENETIC COUNSELING; HUMANS; MALE;

EID: 33644854045     PISSN: 15276546     EISSN: 15475069     Source Type: Journal    
DOI: 10.1111/j.1547-5069.2005.00055.x     Document Type: Review

References (36)

1. Ahmad, F. (2003). The molecular genetics of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Clinical Investigational Medicine, 26 (4 167 178.
2. Benson, D.W., Silberbach, G.M., Kavanaugh-McHugh, A., Cottrill, C., Zhang, Y., Riggs, S., et al. (1999). Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. Journal of Clinical Investigation, 104, 1567 1573.
3. Casas, J.P., Bautista, L.E., Humphries, S.E., & Hingorani, A.D. (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: Meta-analysis of 26 studies involving 23028 subjects. Circulation, 109 (11 1359 1365.
4. Chiodini, B.D., Barlera, S., Franzosi, M.G., Beceiro, V.L., Introna, M., & Tognoni, G. (2003). APO B gene polymorphisms and coronary artery disease: A meta-analysis. Atherosclerosis, 167, 355 366.
5. Collins, F.S., Green, E., Guttmacher, A.E., & Guyer, M.S. (2003). A vision for the future of genomic research. Nature, 422, 835 847.
6. Corrado, D., Basso, C., Thiene, G., McKenna, W.J., Davies, M.J., Fontaliran, F., et al. (1997). Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. Journal of the American College of Cardiology, 30, 1512 1520.
7. Corrado, D., Pelliccia, A., Bjornstad, H.H., Vanhees, L., Biffi, A., Borjesson, M., et al. (2005) Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: Proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. European Heart Journal, 26, 516 524.
8. Epstein, S.E., Zhou, Y.F., & Zhu, J. (1999). Infection and atherosclerosis emerging mechanistic paradigms. Circulation, 100, e20-e28.
9. Fatkin, D., & Graham, R.M. (2002). Molecular mechanisms of inherited cardiomyopathies. Physiological Reviews, 82 (4 945 980.
10. Frazier, L., Turner, S.T., Schwartz, G.L., Chapman, A.B., & Boerwinkle, E. (2004). Multilocus Effects of the renin angiotensin aldosterone system genes on blood pressure response to a diuretic. Pharmacogenomics Nature, 4, 17 23.
11. Hart, P.L. (2005). Women's perceptions of coronary heart disease: An integrative review. Journal of Cardiovascular Nursing, 20 (3 170 176.
12. Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., et al. (2004). The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genetics, 3, 233 239.
13. Holtzman, N.A., Murphy, P.D., Watson, M.S., & Barr, P.A. (1997). Predictive genetic testing: From basic research to clinical practice. Science, 24 278 (5338 602 605.
14. Ichida, F., Tsubata S., Bowles, K.R., Haneda, N., Uese, K., Miyawaki, T., et al. (2001). Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation, 103 (9 1256 1263.
15. Kandolf, R., & Hofscheider, P.H. (1989 Viral heart disease Springer Seminars in Immunological Pathology, 11, 1 13.
16. Kenton, A.B., Sanchez, X., Coveler, K.J., Makar, K.A., Jimenez, S., & Ichida, F. (2004). Isolated left ventricular noncompaction is rarely caused by mutations in G4.5, alpha-dystrobrevin and FK Binding Protein-12. Molecular Genetic Metabolism, 82 (2 162 166.
17. Kwiterovich, P.O., Jr. (2002). Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. American Journal of Cardiology, 90 (8A 30i-47i.
18. Maron, B.J., Roberts, W.C., & Epstein, S.E. (1982). Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation, 65 (7 1388 1394.
19. Masson, L.F., & McNeill, G. (2005). The effect of genetic variation on the lipid response to dietary change: Recent findings. Current Opinion in Lipidology, 16 (1 61 67.
20. McKenna, W.J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. British Heart Journal, 71, 215 218.
21. Metcalfe, B., Sellers, K., Jeng, M., Huentelman, M., Latovich, M., & Raizada, M. (2001). Gene theraphy for cardiovascular disorders: Is there a future? Annals of the New York Academy of Sciences, 953, 31 42.
22. Mizuguchi, T., Collod-Beroud, G., Akiyama, T., Abifadel, M., Harada, N., Morisaki, T., et al. (2004). Heterozygous TGFBR2 mutations in Marfan syndrome. Nature Genetics, 36, 855 60.
23. Moolman, J.C., Corfield, V.A., Posen, B., Ngumbela, K., Seidman, C., Brink, P.A., et al. (1997). Sudden death due to troponin T mutations. Journal of the American College of Cardiology, 29, 549 555.
24. Murdoch, J.L., Walker, B.A., & McKusick, V.A. (1972). Life expectancy and causes of death in the Marfan syndrome. New England Journal of Medicine, 286, 804 808.
25. Niimura, H., Bachinski, L.L., Sangwatanaroj, S., Watkins, H., Chudley, A., & McKenna, W. (1998). Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. New England Journal of Medicine, 338, 1248 1257.
26. Page, G.P., George, V., Go, R.C., Page, P.Z., & Allison, D.B. (2003). Are we there yet?: Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. American Journal of Human Genetics, 73 (4 711 719.
27. Richardson, P., McKenna, W., Bristow, M., Maisch, B., Maunter, B., O'Connell, J., et al. (1996). Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force. The definition and classification of cardiomyopathies. Circulation, 93, 841 842.
28. Seidman, J.G., & Seidman, C. (2001). The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell, 23, 104 (4 557 567.
29. Seidman, C.E., McKenna, W.J., et al. (1992). Molecular genetic approaches to diagnosis and management of hypertrophic cardiomyopathy. In E. Braunwald (Ed. Heart disease. A textbook of cardiovascular medicine (pp. 77 83). New York : Saunders.
30. Taylor, A., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Jr., Ferdinand, K., et al. (2004). Combination of isosorbide dinitrate and hydralizine in Blacks with heart failure. New England Journal of Medicine, 351, 2049 2057.
31. Thiene, G.A., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. New England Journal of Medicine, 318, 129 133.
32. Watkins, H.D., Conner, D., Thierfelder, L., Jarcho, J.A., MacRae, C., McKenna, W.J., et al. (1995). Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genetics, 11, 434 437.
33. Watkins, H.W., McKenna, J., Thierfelder, L., Suk, H.J., Anan, R., O'Donoghue, A., et al. (1995). Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. New England Journal of Medicine, 332, 1058 1064.
34. Watson, K.E., & Topol, E.J. (2004). Pathobiology of atherosclerosis: Are there racial and ethnic differences? Reviews in Cardiovascular Medicine, 5 Suppl. 14, S14 S21.
35. World Health Organization 2003). The World Health Report 2003: Shaping the future (chap. 6). Retrieved April 14, 2005, from http://www.who.int/whr/ 2003/chapter6/en/print.html
36. World Health Organization 2004, September 23). WHO publishes definitive atlas on global heart disease and stroke epidemic. Retrieved April 14, 2005, from http://www.who.int/mediacentre/news/releases/2004/pr68/en/index.html